Long-term follow-up of dose-dense neoadjuvant chemotherapy in patients with stage II/III breast cancer

被引：1
|
作者：
Nimmagadda, S. [1 ]
Nabell, L. [1 ]
Carpenter, J. T. [1 ]
Falkson, C. I. [1 ]
Krontiras, H. [1 ]
De Los Santos, J. F. [1 ]
Urist, M. M. [1 ]
Bland, K. I. [1 ]
LoBuglio, A. F. [1 ]
Li, Y. [1 ]
Forero-Torres, A. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e11048
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11048
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy of dose-dense neoadjuvant chemotherapy in patients with stage II or III breast cancers
    Zarcos, J.
    Blancas, I.
    Calvo, A.
    Legeren, M.
    Jurado, J. M.
    Delgado, M.
    Fonseca, R.
    Gonzalez, A. R.
    Suarez, L.
    Puche, J. L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S472 - S473
  • [2] Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
    Landman, Yosef
    Stemmer, Salomon Marcello
    Sulkes, Aaron
    Neiman, Victoria
    Granot, Tal
    Hendler, Daniel
    Kramer, Mordechai Reuven
    Gelmon, Karen
    Yerushalmi, Rinat
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [3] Safety and effectiveness of dose dense neoadjuvant chemotherapy in patients with stage II/III breast cancer
    Koya, S.
    Li, Y.
    McDaniel, S. A.
    LoBuglio, A. F.
    Krontiras, H.
    Carpenter, J.
    Nabell, L.
    Bland, K.
    Falkson, C.
    Forero, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Phase II study of neoadjuvant dose-dense docetaxel in stage II/III breast cancer.
    Chakravarthy, B.
    Mayer, I. A.
    Meszoely, I
    Means-Powell, J.
    Kelley, M. C.
    Grau, A.
    Johnson, D. H.
    McLaren, B. N.
    Broome, E. E.
    Pietenpol, J. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S148 - S148
  • [5] Long-term follow-up of HER2-overexpressing stage II or III breast cancer treated by anthracycline-free neoadjuvant chemotherapy
    Guiu, S.
    Liegard, M.
    Favier, L.
    van Praagh, I.
    Largillier, R.
    Weber, B.
    Coeffic, D.
    Moreau, L.
    Priou, F.
    Campone, M.
    Gligorov, J.
    Vanlemmens, L.
    Trillet-Lenoir, V.
    Arnould, L.
    Coudert, B.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 321 - 328
  • [6] Dose-dense neoadjuvant chemotherapy in breast cancer.
    Catane, R
    Kaufman, B
    Zach, L
    Wolf, I
    Gluck, I
    Modiano, T
    Barsuk, D
    Shabtai, M
    Papa, M
    Paluch-Shimon, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 79S - 79S
  • [7] Classifications of Pathological Response and Long-Term Follow-Up in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Corben, A. D.
    Teo, C.
    AbiRaad, R.
    Bombonati, A.
    Koerner, F. C.
    Taghian, A.
    Brachtel, E. F.
    MODERN PATHOLOGY, 2011, 24 : 34A - 35A
  • [8] Classifications of Pathological Response and Long-Term Follow-Up in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Corben, A. D.
    Teo, C.
    AbiRaad, R.
    Bombonati, A.
    Koerner, F. C.
    Taghian, A.
    Brachtel, E. F.
    LABORATORY INVESTIGATION, 2011, 91 : 34A - 35A
  • [9] Clinical significance of neoadjuvant dose-dense chemotherapy for II and III stage breast cancer: A meta-analysis of published studies
    Liu, M. C.
    Li, Y.
    Ma, X.
    Zhang, L.
    Yao, X.
    Wang, Q.
    Wang, D.
    Shi, J.
    Li, J.
    Zhang, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S1253 - S1253
  • [10] Long-term Follow-up of Breast-conserving Therapy in Patients with Inflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy
    Bonev, Valentina
    Evangelista, Maristella
    Chen, Jeon-Hor
    Su, Min-Ying
    Lane, Karen
    Mehta, Rita
    Butler, John
    Hsiang, David
    AMERICAN SURGEON, 2014, 80 (10) : 940 - 943
12345